相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffii
Neil C. Dalvie et al.
BIOTECHNOLOGY AND BIOENGINEERING (2022)
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses
Tiong Kit Tan et al.
NATURE COMMUNICATIONS (2021)
Comparison of Different Signal Peptides for the Efficient Secretion of the Sweet-Tasting Plant Protein Brazzein in Pichia pastoris
Fabrice Neiers et al.
LIFE-BASEL (2021)
Modifications in the Kex2 P1′ cleavage site in the α-MAT secretion signal lead to higher production of human granulocyte colony-stimulating factor in Pichia pastoris
Sakshi Aggarwal et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2021)
Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus
Neil C. Dalvie et al.
MICROBIAL CELL FACTORIES (2021)
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
Neil C. Dalvie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Comparative genome-scale analysis of Pichia pastoris variants informs selection of an optimal base strain
Joseph R. Brady et al.
BIOTECHNOLOGY AND BIOENGINEERING (2020)
Host-Informed Expression of CRISPR Guide RNA for Genomic Engineering in Komagataella phaffii
Neil C. Dalvie et al.
ACS SYNTHETIC BIOLOGY (2020)
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
Wen-Hsiang Chen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
A combined screening and in silico strategy for the rapid design of integrated downstream processes for process and product-related impurity removal
Nicholas Vecchiarello et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Continuous integrated manufacturing of therapeutic proteins
Daniel Johannes Karst et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
The yeast stands alone: the future of protein biologic production
Kerry R. Love et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
On-demand manufacturing of clinical-quality biopharmaceuticals
Laura E. Crowell et al.
NATURE BIOTECHNOLOGY (2018)
Recent advances of molecular toolbox construction expand Pichia pastoris in synthetic biology applications
Zhen Kang et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2017)
Structural characterization of the α-mating factor prepro-peptide for secretion of recombinant proteins in Pichia pastoris
Sabreen Chahal et al.
GENE (2017)
Cell Factory Engineering
Anne Mathilde Davy et al.
CELL SYSTEMS (2017)
Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms
Catherine B. Matthews et al.
BIOTECHNOLOGY AND BIOENGINEERING (2017)
Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production
Mudassar Ahmad et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Inclusion of a universal tetanus toxoid CD4+ T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines
Xiaobo Wen et al.
VACCINE (2014)
Endogenous signal peptides efficiently mediate the secretion of recombinant proteins in Pichia pastoris
Shuli Liang et al.
BIOTECHNOLOGY LETTERS (2013)
The effect of α-mating factor secretion signal mutations on recombinant protein expression in Pichia pastoris
Geoff P. Lin-Cereghino et al.
GENE (2013)
Combined strategies for improving the heterologous expression of an alkaline lipase from Acinetobacter radioresistens CMC-1 in Pichia pastoris
Xiaolan Zhao et al.
PROCESS BIOCHEMISTRY (2013)
Enabling global access to high-quality biopharmaceuticals
J. Christopher Love et al.
CURRENT OPINION IN CHEMICAL ENGINEERING (2013)
The secretory pathway: exploring yeast diversity
Marizela Delic et al.
FEMS MICROBIOLOGY REVIEWS (2013)
Synthesis and secretory expression of hybrid antimicrobial peptide CecA-mag and its mutants in Pichia pastoris
Xiuqing Wang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements
Chung-Jr Huang et al.
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2012)
A REVIEW SIZE-EXCLUSION CHROMATOGRAPHY FOR THE ANALYSIS OF PROTEIN BIOTHERAPEUTICS AND THEIR AGGREGATES
Paula Hong et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2012)
Evaluation of Protein Engineering and Process Optimization Approaches to Enhance Antibody Drug Manufacturability
Greg P. Conley et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production
Jianxin Ye et al.
BIOTECHNOLOGY PROGRESS (2011)
Identification of the dipeptidyl aminopeptidase responsible for N-terminal clipping of recombinant Exendin-4 precursor expressed in Pichia Pastoris
Lakshmi Prabha et al.
PROTEIN EXPRESSION AND PURIFICATION (2009)
Antibody fragments may be incorrectly processed in the yeast Pichia pastoris
D. G. Kozlov et al.
BIOTECHNOLOGY LETTERS (2008)
Pichia power: India's biotech industry puts unconventional yeast to work
Chandra Shekhar
CHEMISTRY & BIOLOGY (2008)
Secretory expression of interferon-alpha 2b in recombinant Pichia pastoris using three different secretion signals
Anand Ghosalkar et al.
PROTEIN EXPRESSION AND PURIFICATION (2008)
Expression, purification and characterization of human IFN-λ1 in Pichia pastoris
Yun Fei Xie et al.
JOURNAL OF BIOTECHNOLOGY (2007)
Modifications of therapeutic proteins: challenges and prospects
Nigel Jenkins
CYTOTECHNOLOGY (2007)